GBDC vs CNS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GBDC · Golub Capital BDC$12.74 ▼ 1.39%
CNS · Cohen & Steers$73.20 ▼ 0.04%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GBDC +1.8%
- CNS +12.4%
Head to head
| Metric | GBDC | CNS |
|---|---|---|
| Price | $12.74 | $73.20 |
| Change today | ▼ 1.39% | ▼ 0.04% |
| Market cap | $3.31B | $3.76B |
| Return, 3 months | -0.4% | -10.9% |
| Return, year to date | +1.6% | +19.9% |
| Return, 1 year | +2.1% | +10.9% |
| P/E (TTM) | 19.3 | 22.5 |
| P/B | 0.9 | 6.2 |
| P/E percentile vs own 5y | 90th | 48th |
| Dividend yield | 11.30% | 3.59% |
| Revenue growth (YoY, latest qtr) | -31.9% | +10.4% |
| Net profit growth (YoY) | -36.7% | -1.9% |
| Gross margin | – | 49.6% |
| Operating margin | – | 36.2% |
| Net margin | 84.4% | 26.6% |
| Return on equity | 4.5% | – |
| Analyst target vs. price | +6.4% | -6.4% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 57 | 52 |
| 30-day volatility | 20.0% | 34.8% |
| Max drawdown, 1 year | -14.2% | -22.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CNS is the largest of the group by market value.
- CNS has returned the most over the past year.
- GBDC carries the lowest trailing P/E.
- GBDC pays the highest dividend yield.
- CNS is growing revenue fastest.
- GBDC keeps the most profit per dollar of sales.
- GBDC has been the calmest stock over the last 30 days.